Abeona Therapeutics reports Q2 ZEVA Skin revenue of $11.4 million
Abeona Therapeutics said Q2 2026 ZEVA Skin revenue was $11.4 million, up 31% from Q1, after treating five patients in the quarter and expanding to seven activated QTCs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.